Pathology and molecular genetics of astrocytic gliomas
- PMID: 15316624
- DOI: 10.1007/s00109-004-0564-x
Pathology and molecular genetics of astrocytic gliomas
Abstract
Astrocytic gliomas are the most common primary brain tumours. Here we summarize the characteristic neuropathological features of the different types of astrocytic neoplasms according to the World Health Organization classification of tumours of the nervous system. In addition, we report on the present state of the art concerning the molecular genetics of these tumours. Over the past 20 years a number of recurrent chromosomal,genetic and epigenetic alterations have been found to be associated with the different histological types and malignancy grades of astrocytic tumours. However, we are still far from understanding the complex mechanisms that underly tumour initiation and progression in the individual case. Furthermore, the clinical significance of molecular parameters for the diagnostic and prognostic assessment of astrocytic gliomas is still limited. Therefore further investigation of the molecular mechanisms underlying oncogenesis and progression of these most common brain tumours is necessary to improve their diagnostic assessment and to devise novel, individually tailored treatment strategies.
Similar articles
-
Classification and biology of astrocytic gliomas.Forum (Genova). 1998 Jul-Sep;8(3):244-55. Forum (Genova). 1998. PMID: 9755290 Review.
-
Genetic and epigenetic contribution to astrocytic gliomas pathogenesis.J Neurochem. 2019 Jan;148(2):188-203. doi: 10.1111/jnc.14616. Epub 2018 Dec 3. J Neurochem. 2019. PMID: 30347482 Review.
-
Current concepts in the pathology and genetics of gliomas.Indian J Cancer. 2009 Apr-Jun;46(2):108-19. doi: 10.4103/0019-509x.49148. Indian J Cancer. 2009. PMID: 19346644 Review.
-
Pathology and molecular genetics of oligodendroglial tumors.J Mol Med (Berl). 2004 Oct;82(10):638-55. doi: 10.1007/s00109-004-0565-9. J Mol Med (Berl). 2004. PMID: 15322700 Review.
-
Pathology of low- and intermediate-grade gliomas.Semin Radiat Oncol. 2001 Apr;11(2):95-102. doi: 10.1053/srao.2001.21412. Semin Radiat Oncol. 2001. PMID: 11285547
Cited by
-
Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.Neuro Oncol. 2013 Nov;15(11):1518-31. doi: 10.1093/neuonc/not099. Epub 2013 Jul 25. Neuro Oncol. 2013. PMID: 23887941 Free PMC article.
-
Increased expression of EphA7 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.BMC Cancer. 2008 Mar 25;8:79. doi: 10.1186/1471-2407-8-79. BMC Cancer. 2008. PMID: 18366728 Free PMC article.
-
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response.Cancers (Basel). 2019 Jun 13;11(6):825. doi: 10.3390/cancers11060825. Cancers (Basel). 2019. PMID: 31200581 Free PMC article.
-
Identification of novel SNPs in glioblastoma using targeted resequencing.PLoS One. 2011;6(6):e18158. doi: 10.1371/journal.pone.0018158. Epub 2011 Jun 10. PLoS One. 2011. PMID: 21695249 Free PMC article.
-
Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH.Brain Pathol. 2008 Jul;18(3):326-37. doi: 10.1111/j.1750-3639.2008.00122.x. Epub 2008 Mar 26. Brain Pathol. 2008. PMID: 18371186 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous